Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymosin Beta 4 dose-response study in venous stasis ulcers
2005-004500-37Phase 2Completed
- Sponsor
- Leadiant Biosciences
- Start
- Aug 2006
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in stasis ulcer and venous stasis comparing Thymosin Beta 4 topical treatment with Placebo control (2 arms). Primary endpoint: Safety and tolerability of topical thymosin beta 4. Started Aug 2006; status: completed.
02
Drugs
thymosin beta-4
03
Conditions
stasis ulcervenous stasis
Beyond the preview
Go deeper on 2005-004500-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004500-37.